BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27558169)

  • 1. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
    Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
    Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease.
    Krasemann S; Neumann M; Luepke JP; Grashorn J; Wurr S; Stocking C; Glatzel M
    Acta Neuropathol; 2012 Jul; 124(1):111-26. PubMed ID: 22271154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory response of microglia to prions is controlled by sialylation of PrP
    Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
    Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
    Carroll JA; Chesebro B
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Homeostatic Microglia Signature in Prion Diseases.
    Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
    Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
    Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
    Roettger Y; Zerr I; Dodel R; Bach JP
    PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid associated proteins in Alzheimer's and prion disease.
    Veerhuis R; Boshuizen RS; Familian A
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unaltered prion disease in mice lacking developmental endothelial locus-1.
    Zhu C; Li Z; Li B; Pfammatter M; Hornemann S; Aguzzi A
    Neurobiol Aging; 2019 Apr; 76():208-213. PubMed ID: 30743056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
    Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
    Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells and prions: a license to replicate.
    Nuvolone M; Aguzzi A; Heikenwalder M
    FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.
    Mabbott NA; Bradford BM; Pal R; Young R; Donaldson DS
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.